Meclizine
/api/v1/drug/meclizineMechanism of action
Sourced from openFDAMechanism-of-action classes: Cholinergic Muscarinic Antagonists; Histamine H1 Receptor Antagonists.
Indications
Sourced from openFDA- Uses prevents and treats nausea, vomiting or dizziness associated with motion sicknessICD-10: R11.2
Dosage & administration
Sourced from openFDADirections dosage should be taken one hour before travel starts chew or crush tablets completely before swallowing; do not swallow tablets whole adults and children 12 years and over: take 1 to 2 chewable tablets once daily or as directed by a doctor
Warnings & precautions
Sourced from openFDADo not use in children under 12 years of age unless directed by a doctor. Ask a doctor before use if you have difficulty in urination due to enlargement of the prostate gland glaucoma a breathing problem such as emphysema or chronic bronchitis Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers. When using this product avoid alcoholic beverages alcohol, sedatives, and tranquilizers may increase drowsiness drowsiness may occur use caution when driving a motor vehicle or operating machinery If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Approval history
Sourced from openFDA- Feb 14, 1957NDANDA010721Casper Pharma Llc
- Jun 4, 2010ANDAANDA040659Jubilant Cadista
- Feb 23, 2011ANDAANDA201451Amneal Pharms
- Apr 13, 2012ANDAANDA200294Epic Pharma Llc
- Sep 17, 2012ANDAANDA202640Aurobindo Pharma Usa
- Jun 23, 2020ANDAANDA213957Zydus Lifesciences
- Aug 11, 2022ANDAANDA203003Chartwell Rx
FAERS reports
- 1Dizziness1,91410%
- 2Nausea1,6978.9%
- 3Fatigue1,6108.4%
- 4Headache1,2426.5%
- 5Diarrhoea1,2066.3%
- 6Fall1,1786.2%
- 7Pain1,1586.1%
- 8Dyspnoea9875.2%
- 9Asthenia9595.0%
- 10Drug Ineffective9585.0%
- 11Chronic Kidney Disease9044.7%
- 12Vomiting8874.6%
- 13Vertigo7203.8%
- 14Anxiety7193.8%
- 15Off Label Use7073.7%
Literature
Recent PubMed references pinned to Meclizine as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.
- Efficacy and Safety of Oral Meclizine for Growth Promotion in Children with Achondroplasia: A Phase 2 Clinical Trial.Calcified tissue international · 2025 · Matsushita M, Kitoh H, Kubota T, et al.PMID 41326861DOI 10.1007/s00223-025-01449-8
- BAGI-Validated First Derivative Synchronous Fluorescence Spectroscopy for Sustainable Impurity Profiling of Meclizine: Clinical Implications for Maternal-Fetal Safety.Luminescence : the journal of biological and chemical luminescence · 2025 · El Abass SA, Altamimi ASA, Aldakhil T, et al.PMID 41231437DOI 10.1002/bio.70360
- QbD-Based HPLC Method Development for Trace-Level Detection of Genotoxic 3-Methylbenzyl Chloride in Meclizine HCl Formulations.Biomedical chromatography : BMC · 2025 · Chintalapudi NKK, Podila N, Chollety VK, et al.PMID 41126681DOI 10.1002/bmc.70238
- Meclizine seasickness medication and its effect on central nervous system oxygen toxicity in a murine model.Diving and hyperbaric medicine · 2024 · Wiener G, Jamison A, Tal D, et al.PMID 39675737DOI 10.28920/dhm54.4.296-300
- Mechanism of Action and Translational Potential of (S)-Meclizine in Preemptive Prophylaxis Against Stroke.Stroke · 2024 · Lee JH, Gohil VM, Heidari P, et al.PMID 38572656DOI 10.1161/STROKEAHA.123.044397
- Meclizine improves endometrial repair and reduces simulated menstrual bleeding in mice with induced adenomyosis.American journal of obstetrics and gynecology · 2024 · Mao C, Liu X, Guo SW, et al.PMID 38367751DOI 10.1016/j.ajog.2024.02.016
- Unraveling the Structure of Meclizine Dihydrochloride with MicroED.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024 · Lin J, Unge J, Gonen T, et al.PMID 38044280DOI 10.1002/advs.202306435
- Phase 1b study on the repurposing of meclizine hydrochloride for children with achondroplasia.PloS one · 2023 · Matsushita M, Kitoh H, Mishima K, et al.PMID 37428729DOI 10.1371/journal.pone.0283425
Clinical trials
The 10 most recently updated of 10 ClinicalTrials.gov registrations naming Meclizine as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- Motion Sickness Medications and Vestibular Time ConstantCompleted · Phase 4 · Interventional · 54 enrolled · Medical Corps, Israel Defense ForceNCT03270839updated 2025-10-03
- Meclizine for Hepatocellular CarcinomaCompleted · Phase 1 · Interventional · 13 enrolled · Tannaz ArmaghnayNCT03253289updated 2024-10-02
- Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor PerformanceRecruiting · Phase 2 · Interventional · 80 enrolled · Repurposed Therapeutics, Inc.NCT05852730updated 2024-05-16
- Non Inferiority of Meclin® (Meclizine Chlorhydrate) Versus Dramin® (Dimenhydrinate) in Control of Acute Vertigo Symptoms From Peripheral OriginCompleted · Phase 3 · Interventional · 292 enrolled · Apsen Farmaceutica S.A.NCT02112578updated 2023-02-08
- Evaluation of Meclizine Orodispersible Tablet Pharmacokinetic in Human VolunteersUnknown · Phase 1 · Phase 2 · Interventional · 6 enrolled · Mansoura UniversityNCT04564144updated 2020-09-25
- Meclizine Plasma Levels in Responders and Non-respondersUnknown · Phase 4 · Interventional · 50 enrolled · Medical Corps, Israel Defense ForceNCT04482985updated 2020-07-23
- Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) ProphylaxisCompleted · Interventional · 27,034 enrolled · Vanderbilt UniversityNCT02625181updated 2019-03-07
- Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED PatientsCompleted · Interventional · 26 enrolled · Lehigh Valley HospitalNCT00641797updated 2018-04-03
- Meclizine as a Potential Smoking Cessation TreatmentCompleted · Phase 2 · Interventional · 146 enrolled · Duke UniversityNCT01443858updated 2014-08-01
- The Effects of Antihistamines on Pre-Pulse InhibitionCompleted · Phase 1 · Interventional · 117 enrolled · Duke UniversityNCT01537471updated 2013-01-16
Pharmacogenomics
CPIC-curated drug–gene pairs for Meclizine. Levels describe the strength of curated evidence and guideline status — never a recommendation to test or to adjust therapy.
- CYP2D6CPIC B/C (provisional)FDA label: Actionable PGx
Structural analogs
Ranked by 2D fingerprint (Tanimoto) similarity over PubChem structures. Structural proximity only — not a claim of therapeutic equivalence.
Frequently asked questions
- How does Meclizine work?
- Mechanism-of-action classes: Cholinergic Muscarinic Antagonists; Histamine H1 Receptor Antagonists.
- What is Meclizine used for?
- According to FDA labeling, Meclizine carries indications including: Uses prevents and treats nausea, vomiting or dizziness associated with motion sickness. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
- What class of drug is Meclizine?
- Meclizine is classified as Piperazine derivatives, Antiemetic, Cholinergic Muscarinic Antagonists, Histamine H1 Receptor Antagonists, Decreased Acetylcholine Activity, Decreased Histamine Activity, Emesis Suppression.
- What are the brand names for Meclizine?
- Meclizine is marketed under brand names including Antivert, Bonine, Dramamine Less Drowsy, Dramamine Nausea Relief, Pepto Nausea, Verticalm, Wal-Dram 2, Zentrip.
meclizine is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.